moxifloxacin has been researched along with Complication, Postoperative in 72 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 21 (29.17) | 29.6817 |
2010's | 36 (50.00) | 24.3611 |
2020's | 15 (20.83) | 2.80 |
Authors | Studies |
---|---|
Chuck, RS; Jung, MY; Kim, DJ; Kim, M; Pak, HJ; Park, CY; Park, JH | 1 |
Das, T; Dave, VP; Joseph, J; Reddy, JC; Sharma, S; Singh, VM | 1 |
Donnenfeld, ED; Hovanesian, JA | 1 |
Gümüş, G; Kara, N; Karatas Durusoy, G; Öcal, MC | 1 |
Horita, N; Kaneko, T; Kato, A; Masuhara, N; Mizuki, N; Namkoong, H; Nomura, E; Takeuchi, M | 1 |
Jeeva, IK; Masud, S; Siddiqui, MAR | 1 |
Chang, DF; Mah, FS; Mamalis, N; Miller, KM; Myers, WG; Shorstein, NH | 1 |
Bena, J; Gans, R; Goshe, J; Li, A; Shao, J | 1 |
Mamalis, N | 1 |
Mansoori, T; Reddy, AK; Sistla, A; Srirampur, A; Suresh, N | 1 |
Benetz, BA; Chang, DF; Gardner, S; Lass, JH; Menegay, HJ; OʼBrien, RC; Prajna, NV; Rajendrababu, S; Rhee, DJ; Shekar, M; Szczotka-Flynn, LB | 1 |
Das, T; Khanna, RC; Rathi, VM; Sharma, S | 1 |
Ho, AC; Patel, SN; Peck, TJ | 1 |
Kong, J; Lei, S; Li, X; Liu, J; Ma, Z; Yan, T; Yin, N; Zhang, X; Zhang, Y | 1 |
Agrawal, R; Bhatia, P; Goh, EJH; Kashikar, R; Kohli, GM; Naman, V; Sachdeva, M; Sen, A; Sen, P; Shenoy, P; Sood, D | 1 |
Jethani, JN; Mathew, BC; Patel, A; Porwal, AC | 1 |
Libre, PE; Mathews, S | 1 |
Tripathy, K | 1 |
Boianovsky, C; Godoy, RB; Lake, J; Saraiva, TJ; Vieira, IV | 1 |
Flynn, HW; Grzybowski, A; Relhan, N; Schwartz, SG | 1 |
Anuradha, A; Nishath, S; Rashmi, G; Shilpa, R; Vidyadevi, M | 1 |
Chang, CH; Chang, YY; Lu, PH | 1 |
Ferreira, KSA; Gaete, MIL; Lira, RPC; Lucena, NP; Mélega, MV; Pereira, IMS | 1 |
Font Juliá, E; Hernández Pardines, F; Molina Martin, JC; Serra Verdú, MC | 1 |
Galvis, V; Gómez, MA; Grice, JM; Niño, CA; Tello, A | 1 |
Gibbons, A; Koch, DD; Leung, EH; Stout, JT | 1 |
Lu, B; Xiang, L | 1 |
He, YG; Patel, SB; Reddy, NK | 1 |
Hwang, FS; Kim, J; LeClair, B; Nassiri, S; Pham, M; Rauser, ME; Yoon, E | 1 |
Benchekroun, S; Cherkaoui, O; El Hachimi, R; El Hadiri, R; Saoiabi, Y | 1 |
Heidary, G; Somsen, D | 1 |
Chang, DF; Haripriya, A; Ravindran, RD | 2 |
Apsey, D; Caldwell, M; Cousineau-Krieger, C; Hensley, D; Panday, VA; Reilly, C | 1 |
Ackmann, S; Baron, A; Büchler, MW; Daniel, D; Encke, J; Feilhauer, K; Golling, MT; Götze, T; Gutt, CN; Harnoss, JC; Kipfmüller, K; Klar, E; Köninger, J; Menges, M; Ridwelski, K; Schön, MR; Schunter, O; Seitz, HK; Stremmel, W; Weigand, K; Zoller, WG | 1 |
Büchler, MW; Strobel, O | 1 |
Rudnisky, CJ; Wan, D; Weis, E | 1 |
Balkman, JD; Ball, PA; Bauer, DF; Lollis, SS; Whitson, WJ | 1 |
Baviera, J; Beltran, J; Djodeyre, MR; Llovet-Osuna, F; Llovet-Rausell, A; Ortega-Usobiaga, J | 1 |
Chang, DF; Haripriya, A; Namburar, S; Ravindran, RD; Smita, A | 1 |
Bailey, R; Haller, JA; Hark, LA; Roman, JS; Tyson, SL; Zhan, T | 1 |
Gupta, PC; Ram, J | 1 |
Arshinoff, SA; Modabber, M | 1 |
Arbisser, LB | 1 |
Fiscella, RG; Jensen, MK; Mooney, B; Moshirfar, M | 1 |
Holland, EJ; Lane, SS; Lindstrom, RL | 1 |
McCulley, JP | 1 |
Callegan, MC; Moyer, AL; Novosad, BD; Ramadan, RT; Wiskur, B | 1 |
Bachinskaia, EN; Beloborodova, NV; Kuznetsova, ST; Popov, DA; Vostrikova, TIu | 1 |
Kaczmarzyk, T | 1 |
Pacheco, PA; Tam, PM | 1 |
Becker, J; Chatzikyrkou, C; Clajus, C; Hafer, C; Hamwi, I; Kielstein, JT | 1 |
Agarwal, T; Jhanji, V; Sharma, N; Vajpayee, RB | 1 |
Desai, RU; Enriquez, B; Schrier, A; Shaw, J; Smith, EF | 1 |
Chee, SP | 1 |
Hooper, CY; Khan, A; Lightman, SL; Pacheco, P; Tam, PM; Taylor, SR | 1 |
Bosjolie, A; Qiao, M; Shih, CY; Udell, IJ | 1 |
Herrinton, LJ; Shorstein, NH; Winthrop, KL | 1 |
Arvis, P; Breilh, D; Djabarouti, S; Gordien, JB; Jougon, J; Landreau, V; Saux, MC; Velly, JF; Xuereb, F | 1 |
Kumar, R; Marx, DP; Moshirfar, M | 1 |
Lee, SB; Mohan, SK; Oliver, KM; Slomovic, AR; Strube, YN | 1 |
Feiz, V; Kang, PC; Mirzaian, G; Moshirfar, M | 1 |
Fiscella, RG; Jensen, MK | 1 |
Deramo, VA; Fastenberg, DM; Lai, JC; Udell, IJ | 1 |
Murthy, SI; Sahu, SK; Sangwan, VS; Thomas, R | 1 |
Basavanthappa, S; Feiz, V; Moshirfar, M; Vitale, AT; Wegelin, JA; Wolsey, DH | 1 |
Bower, KS; Colyer, MH; Dick, JS; Haller, JA; Ward, TP; Weber, ED; Weichel, ED | 1 |
Arshinoff, SA; Mah, FS; O'Brien, TP | 1 |
Belfort, R; Freitas, LL; Höfling-Lima, AL; Muccioli, C; Soriano, E | 1 |
Delgado, J; Diaz, LA; Galvis, V; Gómez, AJ; Tello, A; Valencia, F | 1 |
Balzli, CL; Caballero, AR; Huang, B; McCormick, CC; O'Callaghan, RJ; Smith, E; Tang, A; Wigington, L | 1 |
Bohigian, GM | 1 |
8 review(s) available for moxifloxacin and Complication, Postoperative
Article | Year |
---|---|
Prophylactic antibiotics for postcataract surgery endophthalmitis: a systematic review and network meta-analysis of 6.8 million eyes.
Topics: Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cataract Extraction; Cefuroxime; Endophthalmitis; Humans; Moxifloxacin; Network Meta-Analysis; Postoperative Complications; Vancomycin | 2022 |
Endophthalmitis after cataract surgery: an update on recent advances.
Topics: Anti-Bacterial Agents; Cataract Extraction; Drug Implants; Endophthalmitis; Eye Infections, Bacterial; Humans; Moxifloxacin; Postoperative Complications; Vancomycin; Vitrectomy; Vitreous Body | 2021 |
Topical insulin in neurotrophic keratopathy after resection of acoustic neuroma.
Topics: Administration, Ophthalmic; Anti-Bacterial Agents; Combined Modality Therapy; Contact Lenses, Hydrophilic; Corneal Ulcer; Facial Nerve Injuries; Facial Paralysis; Female; Humans; Insulin; Keratitis; Middle Aged; Moxifloxacin; Neuroma, Acoustic; Postoperative Complications; Staphylococcal Infections; Trigeminal Nerve Injuries; Vancomycin | 2019 |
Infection due to Mycoplasma hominis after left hip replacement: case report and literature review.
Topics: Anti-Bacterial Agents; Arthroplasty, Replacement, Hip; Clindamycin; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Mycoplasma hominis; Mycoplasma Infections; Postoperative Complications | 2019 |
Postoperative Mycoplasma hominis infections after neurosurgical intervention.
Topics: Acute Disease; Adolescent; Anti-Bacterial Agents; Cervical Vertebrae; Delayed Diagnosis; Empyema, Subdural; Epidural Abscess; Fluoroquinolones; Humans; Immunosuppression Therapy; Magnetic Resonance Imaging; Male; Moxifloxacin; Mycoplasma hominis; Mycoplasma Infections; Neurosurgical Procedures; Postoperative Complications; Spinal Cord Compression; Spinal Injuries; Surgical Wound Dehiscence; Tomography, X-Ray Computed; Treatment Failure; Treatment Outcome | 2014 |
Clinical outcomes after injection of a compounded pharmaceutical for prophylaxis after cataract surgery: a large-scale review.
Topics: Anti-Bacterial Agents; Drug Compounding; Drug Therapy, Combination; Endophthalmitis; Fluoroquinolones; Glucocorticoids; Humans; Intravitreal Injections; Moxifloxacin; Phacoemulsification; Postoperative Complications; Treatment Outcome; Triamcinolone Acetonide; Vancomycin | 2017 |
Dose and administration of intracameral moxifloxacin for prophylaxis of postoperative endophthalmitis.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Cataract Extraction; Endophthalmitis; Eye Infections, Bacterial; Fluoroquinolones; Humans; Moxifloxacin; Postoperative Complications | 2016 |
Perspectives on antibiotics for postoperative endophthalmitis prophylaxis: potential role of moxifloxacin.
Topics: Anterior Chamber; Anti-Infective Agents; Antibiotic Prophylaxis; Aza Compounds; Cataract Extraction; Endophthalmitis; Eye Infections, Bacterial; Fluoroquinolones; Humans; Moxifloxacin; Postoperative Complications; Quinolines | 2007 |
9 trial(s) available for moxifloxacin and Complication, Postoperative
Article | Year |
---|---|
Intracameral dexamethasone 9% vs prednisolone acetate 1% in controlling postoperative pain and inflammation in patients undergoing cataract surgery.
Topics: Cataract; Cataract Extraction; Dexamethasone; Humans; Inflammation; Moxifloxacin; Ophthalmic Solutions; Pain, Postoperative; Phacoemulsification; Postoperative Complications; Prednisolone; Prospective Studies | 2022 |
Comparative corneal endothelial cell toxicity of differing intracameral moxifloxacin doses after phacoemulsification.
Topics: Aged; Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Corneal Endothelial Cell Loss; Double-Blind Method; Endophthalmitis; Endothelium, Corneal; Female; Humans; Lens Implantation, Intraocular; Male; Middle Aged; Moxifloxacin; No-Observed-Adverse-Effect Level; Phacoemulsification; Postoperative Complications; Prospective Studies; Visual Acuity | 2020 |
Endophthalmitis prophylaxis study. Report 1: Intracameral cefuroxime and moxifloxacin prophylaxis for the prevention of postcataract endophthalmitis in rural India.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cataract Extraction; Cefuroxime; Endophthalmitis; Eye Infections, Bacterial; Female; Humans; India; Male; Middle Aged; Moxifloxacin; Postoperative Complications; Prospective Studies; Young Adult | 2020 |
Acute cholecystitis: early versus delayed cholecystectomy, a multicenter randomized trial (ACDC study, NCT00447304).
Topics: Adult; Aged; Anti-Bacterial Agents; Aza Compounds; Cholecystectomy, Laparoscopic; Cholecystitis, Acute; Combined Modality Therapy; Conversion to Open Surgery; Cost-Benefit Analysis; Drug Administration Schedule; Female; Fluoroquinolones; Germany; Hospital Costs; Humans; Intention to Treat Analysis; Length of Stay; Male; Middle Aged; Moxifloxacin; Postoperative Complications; Prospective Studies; Quinolines; Slovenia; Time Factors; Treatment Outcome | 2013 |
[Early laparoscopic cholecystectomy as therapy of choice for acute cholecystitis].
Topics: Anti-Bacterial Agents; Aza Compounds; Cholecystectomy, Laparoscopic; Cholecystitis, Acute; Conversion to Open Surgery; Early Medical Intervention; Fluoroquinolones; Hospital Costs; Humans; Infusions, Intravenous; Length of Stay; Moxifloxacin; Postoperative Complications; Quinolines | 2013 |
Moxifloxacin punctum plug for sustained drug delivery.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Aza Compounds; Cataract; Cataract Extraction; Conjunctivitis, Bacterial; Delayed-Action Preparations; Double-Blind Method; Drug Delivery Systems; Endpoint Determination; Feasibility Studies; Female; Fluoroquinolones; Humans; Intraocular Pressure; Male; Middle Aged; Moxifloxacin; Postoperative Complications; Prospective Studies; Quinolines; Tears; Time Factors | 2012 |
Diffusion of oral and intravenous 400 mg once-daily moxifloxacin into lung tissue at pharmacokinetic steady-state.
Topics: Administration, Oral; Adult; Antibiotic Prophylaxis; Aza Compounds; Biological Availability; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fluoroquinolones; Follow-Up Studies; Humans; Infusions, Intravenous; Lung; Lung Neoplasms; Male; Middle Aged; Moxifloxacin; Pneumonia, Bacterial; Postoperative Complications; Prospective Studies; Quinolines; Reference Values; Risk Factors; Tissue Distribution; Treatment Outcome | 2003 |
The effect of the fourth-generation fluoroquinolones on corneal reepithelialization after penetrating keratoplasty.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Aza Compounds; Child; Epithelium, Corneal; Eye Infections, Bacterial; Female; Fluoroquinolones; Gatifloxacin; Humans; Keratoplasty, Penetrating; Male; Middle Aged; Moxifloxacin; Postoperative Care; Postoperative Complications; Prospective Studies; Quinolines; Wound Healing | 2005 |
Efficacy and tolerability of a combined moxifloxacin/dexamethasone formulation for topical prophylaxis and reduction of inflammation in phacoemulsification: a comparative, double masked clinical trial.
Topics: Aged; Anti-Infective Agents; Antineoplastic Agents, Hormonal; Aza Compounds; Dexamethasone; Double-Blind Method; Drug Combinations; Female; Fluoroquinolones; Humans; Inflammation; Lens Implantation, Intraocular; Male; Middle Aged; Moxifloxacin; No-Observed-Adverse-Effect Level; Phacoemulsification; Postoperative Complications; Quinolines | 2007 |
55 other study(ies) available for moxifloxacin and Complication, Postoperative
Article | Year |
---|---|
Moxifloxacin releasing intraocular implant based on a cross-linked hyaluronic acid membrane.
Topics: Animals; Anti-Bacterial Agents; Bacterial Infections; Cataract Extraction; Drug Liberation; Drug Resistance, Bacterial; Hyaluronic Acid; Infusion Pumps, Implantable; Moxifloxacin; Postoperative Complications; Pseudomonas aeruginosa; Rabbits; Rats; Staphylococcus aureus | 2021 |
Clinical features and microbiology of post-cataract surgery endophthalmitis with and without intracameral moxifloxacin prophylaxis: Endophthalmitis prophylaxis study report 3.
Topics: Adolescent; Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cataract; Cataract Extraction; Endophthalmitis; Eye Infections, Bacterial; Humans; Moxifloxacin; Postoperative Complications; Retrospective Studies | 2022 |
Cases of toxic anterior segment syndrome after primary pterygium surgery.
Topics: Anterior Eye Segment; Conjunctiva; Eye Diseases; Fibrin; Formaldehyde; Humans; Hyaluronic Acid; Moxifloxacin; Phacoemulsification; Postoperative Complications; Prednisolone; Pterygium; Syndrome | 2022 |
Efficacy and safety of intravitreal injection of triamcinolone-moxifloxacin after cataract surgery in a low to middle income country - a one-year audit.
Topics: Adult; Aged; Cataract; Cataract Extraction; Developing Countries; Endophthalmitis; Eye Diseases; Female; Glucocorticoids; Humans; Inflammation; Intravitreal Injections; Male; Middle Aged; Moxifloxacin; Postoperative Complications; Retrospective Studies; Triamcinolone | 2023 |
ASCRS clinical advisory on intracameral moxifloxacin injection for infection prophylaxis.
Topics: Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cataract Extraction; Endophthalmitis; Eye Infections, Bacterial; Humans; Moxifloxacin; Postoperative Complications | 2023 |
Postoperative Endophthalmitis Before and After Preferred Utilization of Prophylactic Intracameral Antibiotics for Phacoemulsification Cataract Surgeries at Cole Eye Institute.
Topics: Administration, Ophthalmic; Adult; Aged; Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Endophthalmitis; Female; Humans; Injections, Intraocular; Lens Implantation, Intraocular; Male; Middle Aged; Moxifloxacin; Phacoemulsification; Postoperative Complications; Retrospective Studies; Visual Acuity | 2019 |
Reducing the risk of endophthalmitis.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Cataract Extraction; Endophthalmitis; Eye Infections, Bacterial; Humans; Moxifloxacin; Postoperative Complications; Risk Factors; Risk Reduction Behavior | 2019 |
Retrocorneal abscess: an unusual presentation of Nocardia keratitis after Descemet's stripping endothelial keratoplasty.
Topics: Abscess; Aged, 80 and over; Anti-Bacterial Agents; Antihypertensive Agents; Atropine; Corneal Diseases; Descemet Stripping Endothelial Keratoplasty; Eye Infections, Bacterial; Female; Humans; Keratitis; Microbial Sensitivity Tests; Moxifloxacin; Mydriatics; Nocardia; Nocardia Infections; Postoperative Complications; Slit Lamp Microscopy; Tomography, Optical Coherence; Visual Acuity | 2020 |
Thermoresponsive GenisteinNLC-dexamethasone-moxifloxacin multi drug delivery system in lens capsule bag to prevent complications after cataract surgery.
Topics: Cataract Extraction; Cell Line; Dexamethasone; Drug Delivery Systems; Genistein; Lens Capsule, Crystalline; Moxifloxacin; Postoperative Complications; Temperature | 2021 |
Impact of prophylactic intracameral moxifloxacin on post-cataract surgery endophthalmitis: data from a tertiary eye care facility in rural India.
Topics: Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cataract; Cataract Extraction; Endophthalmitis; Eye Infections, Bacterial; Humans; India; Moxifloxacin; Postoperative Complications; Retrospective Studies | 2021 |
Incidence of postoperative endophthalmitis with and without use of intracameral moxifloxacin.
Topics: Anterior Chamber; Anti-Bacterial Agents; Cataract Extraction; Cefuroxime; Endophthalmitis; Eye Infections, Bacterial; Fluoroquinolones; Humans; Incidence; Moxifloxacin; Postoperative Complications | 2021 |
Endophthalmitis prophylaxis by intracameral antibiotics: In vitro model comparing vancomycin, cefuroxime, and moxifloxacin.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Cefuroxime; Endophthalmitis; Eye Infections, Bacterial; Humans; Lens Implantation, Intraocular; Lenses, Intraocular; Moxifloxacin; Postoperative Complications; Vancomycin | 2017 |
Re: Haripriya et al.: Endophthalmitis reduction with intracameral moxifloxacin prophylaxis: analysis of 600 000 surgeries (Ophthalmology. 2017;124:768-775).
Topics: Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cataract Extraction; Endophthalmitis; Eye Infections, Bacterial; Fluoroquinolones; Humans; Moxifloxacin; Postoperative Complications | 2017 |
Safety and efficacy of intracameral moxifloxacin injection for prophylaxis of endophthalmitis after phacoemulsification.
Topics: Aged; Aged, 80 and over; Anterior Chamber; Anti-Bacterial Agents; Endophthalmitis; Female; Fluoroquinolones; Humans; Injections, Intraocular; Male; Middle Aged; Moxifloxacin; Phacoemulsification; Post-Exposure Prophylaxis; Postoperative Complications; Reproducibility of Results; Retrospective Studies; Time Factors; Treatment Outcome | 2017 |
Re: Haripriya et al.: Endophthalmitis reduction with intracameral moxifloxacin prophylaxis: an analysis of 600 000 surgeries (Ophthalmology. 2017;124:768-775).
Topics: Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cataract Extraction; Endophthalmitis; Eye Infections, Bacterial; Fluoroquinolones; Humans; Moxifloxacin; Postoperative Complications | 2017 |
Safety of Fixed drug Combination in Post -Operative Cataract Patients, at Tertiary Care Centre - In South India.
Topics: Anti-Bacterial Agents; Cataract Extraction; Dose-Response Relationship, Drug; Drug Combinations; Endophthalmitis; Female; Fluprednisolone; Follow-Up Studies; Glucocorticoids; Humans; Incidence; India; Intraocular Pressure; Male; Moxifloxacin; Ophthalmic Solutions; Postoperative Care; Postoperative Complications; Prospective Studies; Tertiary Care Centers | 2017 |
Non-Tuberculous Mycobacteria Infection Following Autologous Fat Grafting on the Face.
Topics: Adipose Tissue; Adult; Anti-Bacterial Agents; Clarithromycin; Cosmetic Techniques; Diagnosis, Differential; Face; Female; Fluoroquinolones; Humans; Moxifloxacin; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Postoperative Complications; Tissue and Organ Harvesting; Transplantation, Autologous | 2017 |
Intracameral moxifloxacin after cataract surgery: a prospective study.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibiotic Prophylaxis; Endophthalmitis; Female; Fluoroquinolones; Humans; Injections, Intraocular; Intraocular Pressure; Lens Implantation, Intraocular; Male; Middle Aged; Moxifloxacin; Phacoemulsification; Postoperative Complications; Prospective Studies; Reproducibility of Results; Statistics, Nonparametric; Time Factors; Treatment Outcome; Visual Acuity | 2018 |
Aqueous humor misdirection syndrome after glaucoma filtering surgery in patient with bilateral acute iris transillumination (BAIT) syndrome.
Topics: Anti-Inflammatory Agents; Aqueous Humor; Atrophy; Combined Modality Therapy; Female; Glaucoma Drainage Implants; Glaucoma, Open-Angle; Humans; Iridectomy; Iris; Laser Therapy; Middle Aged; Moxifloxacin; Mydriasis; Phacoemulsification; Postoperative Complications; Prednisone; Syndrome; Trabeculectomy; Vitrectomy | 2018 |
Intracameral moxifloxacin for endophthalmitis prophylaxis after cataract surgery: Cost-effectiveness analysis.
Topics: Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cataract Extraction; Cost-Benefit Analysis; Endophthalmitis; Eye Infections, Bacterial; Humans; Male; Moxifloxacin; Postoperative Complications | 2018 |
TOXIC POSTERIOR SEGMENT SYNDROME AFTER DROPLESS CATARACT SURGERY WITH COMPOUNDED TRIAMCINOLONE-MOXIFLOXACIN.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Cataract Extraction; Drug Therapy, Combination; Electroretinography; Endophthalmitis; Female; Glucocorticoids; Humans; Intravitreal Injections; Male; Middle Aged; Moxifloxacin; Posterior Eye Segment; Postoperative Complications; Retrospective Studies; Syndrome; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity | 2020 |
Comparative analysis of intravitreal triamcinolone acetonide-moxifloxacin versus standard perioperative eyedrops in cataract surgery.
Topics: Administration, Ophthalmic; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Child; Child, Preschool; Corneal Edema; Drug Combinations; Female; Glucocorticoids; Humans; Inflammation; Intraocular Pressure; Intravitreal Injections; Lens Implantation, Intraocular; Male; Middle Aged; Moxifloxacin; Ophthalmic Solutions; Phacoemulsification; Postoperative Complications; Retrospective Studies; Triamcinolone Acetonide | 2019 |
Corneal perforation following inappropriate long-term aggressive use of topical steroid.
Topics: Administration, Ophthalmic; Adrenal Cortex Hormones; Aged, 80 and over; Anti-Bacterial Agents; Cataract Extraction; Contact Lenses, Hydrophilic; Corneal Perforation; Humans; Male; Moxifloxacin; Postoperative Complications; Tissue Adhesives | 2019 |
Rapid onset of orbital cellulitis after uncomplicated strabismus surgery.
Topics: Administration, Ophthalmic; Ampicillin; Anti-Bacterial Agents; Child; Drug Therapy, Combination; Esotropia; Eye Infections, Bacterial; Humans; Male; Moxifloxacin; Oculomotor Muscles; Ophthalmic Solutions; Orbital Cellulitis; Postoperative Complications; Streptococcal Infections; Streptococcus pyogenes; Sulbactam; Tomography, X-Ray Computed; Vancomycin | 2019 |
Endophthalmitis reduction with intracameral moxifloxacin in eyes with and without surgical complications: Results from 2 million consecutive cataract surgeries.
Topics: Aged; Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cataract Extraction; Endophthalmitis; Eye Infections, Bacterial; Female; Humans; India; Lens Implantation, Intraocular; Male; Middle Aged; Moxifloxacin; Phacoemulsification; Posterior Capsular Rupture, Ocular; Postoperative Complications; Registries; Retrospective Studies | 2019 |
Infection following photorefractive keratectomy.
Topics: Anti-Bacterial Agents; Aza Compounds; Bacteria; Contact Lenses; Equipment Contamination; Eye Infections, Bacterial; Fluorometholone; Fluoroquinolones; Glucocorticoids; Humans; Microbial Sensitivity Tests; Moxifloxacin; Myopia; Photorefractive Keratectomy; Postoperative Complications; Prospective Studies; Quinolines | 2013 |
Antibiotic choice for the prophylaxis of post-cataract extraction endophthalmitis.
Topics: Aged; Aged, 80 and over; Alberta; Anti-Bacterial Agents; Antibiotic Prophylaxis; Aza Compounds; Bacteria; Case-Control Studies; Cataract Extraction; Endophthalmitis; Eye Infections, Bacterial; Female; Fluoroquinolones; Hospitals, Private; Hospitals, Public; Humans; Incidence; Male; Moxifloxacin; Postoperative Complications; Prospective Studies; Quinolines; Vancomycin | 2014 |
Incidence of corneal infections after laser in situ keratomileusis and surface ablation when moxifloxacin and tobramycin are used as postoperative treatment.
Topics: Administration, Topical; Adult; Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Corneal Ulcer; Drug Therapy, Combination; Eye Infections, Bacterial; Female; Fluoroquinolones; Humans; Incidence; Keratomileusis, Laser In Situ; Lasers, Excimer; Male; Middle Aged; Moxifloxacin; Myopia; Ophthalmic Solutions; Postoperative Complications; Retrospective Studies; Risk Factors; Tobramycin; Visual Acuity; Young Adult | 2015 |
Efficacy of Intracameral Moxifloxacin Endophthalmitis Prophylaxis at Aravind Eye Hospital.
Topics: Aged; Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cataract Extraction; Charities; Drug Costs; Electronic Health Records; Endophthalmitis; Eye Infections, Bacterial; Fluoroquinolones; Health Care Costs; Hospitals, Private; Hospitals, Public; Hospitals, Special; Humans; India; Male; Middle Aged; Moxifloxacin; Ophthalmology; Postoperative Complications; Registries; Retrospective Studies | 2016 |
Re: Haripriya et al.: Efficacy of intracameral moxifloxacin endophthalmitis prophylaxis at Aravind Eye Hospital (Ophthalmology 2016;123:302-308).
Topics: Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cataract Extraction; Endophthalmitis; Eye Infections, Bacterial; Fluoroquinolones; Humans; Moxifloxacin; Postoperative Complications | 2016 |
Endophthalmitis Reduction with Intracameral Moxifloxacin Prophylaxis: Analysis of 600 000 Surgeries.
Topics: Aged; Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cataract Extraction; Electronic Health Records; Endophthalmitis; Eye Infections, Bacterial; Female; Fluoroquinolones; Humans; India; Lens Implantation, Intraocular; Male; Microsurgery; Middle Aged; Moxifloxacin; Ophthalmic Solutions; Phacoemulsification; Posterior Capsular Rupture, Ocular; Postoperative Complications; Registries; Retrospective Studies | 2017 |
Safety of intracameral moxifloxacin for prophylaxis of endophthalmitis after cataract surgery.
Topics: Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Antibiotic Prophylaxis; Aza Compounds; Cataract Extraction; Endophthalmitis; Eye Infections, Bacterial; Female; Fluoroquinolones; Humans; Injections; Lens Implantation, Intraocular; Macula Lutea; Male; Middle Aged; Moxifloxacin; Postoperative Complications; Prospective Studies; Quinolines; Retrospective Studies; Tomography, Optical Coherence; Treatment Outcome | 2008 |
Third- and fourth-generation fluoroquinolones: retrospective comparison of endophthalmitis after cataract surgery performed over 10 years.
Topics: Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Antibiotic Prophylaxis; Aza Compounds; Ciprofloxacin; Cross-Sectional Studies; Endophthalmitis; Eye Infections, Bacterial; Female; Fluoroquinolones; Gatifloxacin; Humans; Male; Middle Aged; Moxifloxacin; Ofloxacin; Phacoemulsification; Postoperative Complications; Prevalence; Quinolines; Retrospective Studies | 2008 |
Fluoroquinolones and postoperative endophthalmitis.
Topics: Anti-Infective Agents; Antibiotic Prophylaxis; Aza Compounds; Ciprofloxacin; Endophthalmitis; Eye Infections, Bacterial; Fluoroquinolones; Gatifloxacin; Humans; Moxifloxacin; Ofloxacin; Phacoemulsification; Postoperative Complications; Prevalence; Quinolines | 2009 |
Fluoroquinolones and postoperative endophthalmitis.
Topics: Anti-Infective Agents; Antibiotic Prophylaxis; Aza Compounds; Ciprofloxacin; Endophthalmitis; Eye Infections, Bacterial; Fluoroquinolones; Gatifloxacin; Humans; Moxifloxacin; Ofloxacin; Phacoemulsification; Postoperative Complications; Prevalence; Quinolines | 2009 |
Rate of bacterial eradication by ophthalmic solutions of fourth-generation fluoroquinolones.
Topics: Anti-Infective Agents; Aza Compounds; Benzalkonium Compounds; Colony Count, Microbial; Drug Evaluation, Preclinical; Drug Resistance, Bacterial; Endophthalmitis; Eye Infections, Bacterial; Fluoroquinolones; Gatifloxacin; Haemophilus influenzae; Humans; Keratitis; Moxifloxacin; Ophthalmic Solutions; Postoperative Complications; Preservatives, Pharmaceutical; Quinolines; Staphylococcus aureus; Staphylococcus epidermidis; Streptococcus pneumoniae; Time Factors | 2009 |
[New indications for novel fluoroquinolones: moxifloxacin in the treatment of nosocomial infections].
Topics: Adult; Anti-Bacterial Agents; Aza Compounds; Cross Infection; Drug Administration Schedule; Drug Resistance, Multiple, Bacterial; Female; Fluoroquinolones; Humans; Male; Methicillin Resistance; Middle Aged; Moxifloxacin; Postoperative Complications; Quinolines; Treatment Outcome | 2009 |
Abuse of antibiotic prophylaxis in third molar surgeries.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Antibiotic Prophylaxis; Aza Compounds; Fluoroquinolones; Humans; Molar, Third; Moxifloxacin; Postoperative Complications; Quinolines; Randomized Controlled Trials as Topic; Surgical Wound Infection; Time Factors; Tooth Extraction | 2009 |
Oral moxifloxacin and topical amikacin for Mycobacterium abscessus keratitis after laser in situ keratomileusis.
Topics: Administration, Oral; Administration, Topical; Amikacin; Anti-Bacterial Agents; Aza Compounds; Corneal Ulcer; Eye Infections, Bacterial; Female; Fluoroquinolones; Humans; Keratomileusis, Laser In Situ; Moxifloxacin; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Postoperative Complications; Quinolines; Young Adult | 2010 |
Biopsy proven acute interstitial nephritis after treatment with moxifloxacin.
Topics: Acute Disease; Aged; Anti-Bacterial Agents; Anti-Inflammatory Agents; Aza Compounds; Biopsy; Carcinoma, Non-Small-Cell Lung; Creatinine; Edema; Eosinophilia; Fluoroquinolones; Humans; Lung Neoplasms; Male; Moxifloxacin; Nephritis, Interstitial; Pneumonectomy; Pneumonia; Postoperative Complications; Prednisolone; Quinolines | 2010 |
Presumed corneal stromal graft rejection after deep anterior lamellar keratoplasty in a patient with systemic lupus erythematosis.
Topics: Adolescent; Aza Compounds; Cornea; Corneal Edema; Corneal Stroma; Corneal Transplantation; Drug Administration Schedule; Drug Therapy, Combination; Eyeglasses; Female; Fluoroquinolones; Glucocorticoids; Graft Rejection; Humans; Injections, Intravenous; Keratoconus; Lupus Erythematosus, Systemic; Methylprednisolone; Moxifloxacin; Ophthalmic Solutions; Postoperative Complications; Postoperative Period; Prednisolone; Quinolines; Time Factors; Ultrasonography; Visual Acuity | 2010 |
Can intraocular lenses deliver antibiotics intracamerally?
Topics: Anti-Bacterial Agents; Aza Compounds; Chromatography, High Pressure Liquid; Drug Delivery Systems; Endophthalmitis; Fluoroquinolones; Hydrophobic and Hydrophilic Interactions; Lenses, Intraocular; Microbial Sensitivity Tests; Moxifloxacin; Postoperative Complications; Quinolines; Time Factors | 2010 |
Adjunctive antibiotics in the treatment of acute bacterial endophthalmitis following cataract surgery.
Topics: Acute Disease; Administration, Oral; Anti-Bacterial Agents; Aqueous Humor; Aza Compounds; Bacteria; Cataract Extraction; Ciprofloxacin; Endophthalmitis; Eye Infections, Bacterial; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Moxifloxacin; Postoperative Complications; Quinolines; Retrospective Studies; Vancomycin; Visual Acuity; Vitreous Body | 2012 |
Bilateral corneal ulceration in keratoconus.
Topics: Aza Compounds; Collagen; Corneal Stroma; Corneal Ulcer; Cross-Linking Reagents; Doxycycline; Drug Therapy, Combination; Electrocoagulation; Eye Infections, Bacterial; Fluoroquinolones; Humans; Keratoconus; Male; Middle Aged; Moxifloxacin; Photosensitizing Agents; Postoperative Complications; Prostheses and Implants; Prosthesis Implantation; Quinolines; Staphylococcal Infections; Vancomycin | 2012 |
Decreased postoperative endophthalmitis rate after institution of intracameral antibiotics in a Northern California eye department.
Topics: Aged; Anterior Eye Segment; Anti-Bacterial Agents; Antibiotic Prophylaxis; Aza Compounds; Bacteria; California; Cefuroxime; Endophthalmitis; Eye Infections, Bacterial; Fluoroquinolones; Humans; Incidence; Lens Implantation, Intraocular; Moxifloxacin; Phacoemulsification; Postoperative Complications; Quinolines; Vancomycin | 2013 |
Fourth-generation fluoroquinolones in the treatment of mycobacterial infectious keratitis after laser-assisted in situ keratomileusis surgery.
Topics: Anti-Bacterial Agents; Aza Compounds; Clarithromycin; Corneal Ulcer; Drug Therapy, Combination; Eye Infections, Bacterial; Female; Fluoroquinolones; Humans; Keratomileusis, Laser In Situ; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Postoperative Complications; Quinolines; Surgical Flaps; Tobramycin | 2005 |
Fourth-generation fluoroquinolone-resistant bacterial keratitis after refractive surgery.
Topics: Adult; Aza Compounds; Bacteria; Cornea; Corneal Ulcer; Drug Resistance, Bacterial; Drug Therapy, Combination; Eye Infections, Bacterial; Female; Fluoroquinolones; Gatifloxacin; Humans; Keratomileusis, Laser In Situ; Keratoplasty, Penetrating; Lasers, Excimer; Microbial Sensitivity Tests; Moxifloxacin; Myopia; Photorefractive Keratectomy; Postoperative Complications; Pseudomonas Infections; Quinolines; Staphylococcal Infections | 2006 |
Selecting between gatifloxacin and moxifloxacin drops in ambulatory ophthalmic surgery.
Topics: Ambulatory Surgical Procedures; Anti-Bacterial Agents; Aza Compounds; Drug Costs; Eye Infections, Bacterial; Fluoroquinolones; Gatifloxacin; Humans; Moxifloxacin; Ophthalmologic Surgical Procedures; Postoperative Complications; Quinolines | 2006 |
Acute endophthalmitis in eyes treated prophylactically with gatifloxacin and moxifloxacin.
Topics: Acute Disease; Aged; Aged, 80 and over; Anti-Infective Agents; Antibiotic Prophylaxis; Aza Compounds; Bacteria; Cataract Extraction; Drug Resistance, Bacterial; Endophthalmitis; Eye Infections, Bacterial; Female; Fluoroquinolones; Gatifloxacin; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Postoperative Complications; Quinolines; Retrospective Studies | 2006 |
Effect of the fourth-generation fluoroquinolones on corneal reepithelialization after penetrating keratoplasty.
Topics: Anti-Bacterial Agents; Aza Compounds; Epithelium, Corneal; Eye Infections, Bacterial; Fluoroquinolones; Gatifloxacin; Humans; Keratoplasty, Penetrating; Moxifloxacin; Postoperative Complications; Quinolines; Wound Healing | 2006 |
Endophthalmitis after uncomplicated cataract surgery with the use of fourth-generation fluoroquinolones: a retrospective observational case series.
Topics: Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Antibiotic Prophylaxis; Aza Compounds; Bacteria; Endophthalmitis; Eye Infections, Bacterial; Female; Fluoroquinolones; Gatifloxacin; Humans; Male; Middle Aged; Moxifloxacin; Ophthalmic Solutions; Phacoemulsification; Postoperative Complications; Quinolines; Retrospective Studies; Vitreous Body | 2007 |
Delayed intraocular foreign body removal without endophthalmitis during Operations Iraqi Freedom and Enduring Freedom.
Topics: Adult; Anti-Bacterial Agents; Aza Compounds; Combined Modality Therapy; Endophthalmitis; Eye Enucleation; Eye Foreign Bodies; Eye Injuries, Penetrating; Female; Fluoroquinolones; Follow-Up Studies; Humans; Iraq; Levofloxacin; Male; Middle Aged; Military Medicine; Military Personnel; Moxifloxacin; Ofloxacin; Postoperative Complications; Prognosis; Quinolines; Retrospective Studies; Risk Factors; Time Factors; Visual Acuity; Vitrectomy; Vitreoretinopathy, Proliferative; Warfare | 2007 |
Late bacterial keratitis after intracorneal ring segments (Ferrara ring) insertion for keratoconus.
Topics: Adult; Anti-Bacterial Agents; Aza Compounds; Corneal Stroma; Corneal Ulcer; Drug Therapy, Combination; Eye Infections, Bacterial; Female; Fluoroquinolones; Humans; Imipenem; Keratoconus; Microbial Sensitivity Tests; Moxifloxacin; Postoperative Complications; Prostheses and Implants; Prosthesis Implantation; Quinolines; Staphylococcal Infections; Vancomycin | 2007 |
Fluoroquinolone therapy in a rabbit model of post-LASIK methicillin-resistant Staphylococcus aureus keratitis.
Topics: Animals; Anti-Infective Agents; Aza Compounds; Colony Count, Microbial; Corneal Stroma; Corneal Ulcer; Disease Models, Animal; Eye Infections, Bacterial; Fluoroquinolones; Gatifloxacin; Keratomileusis, Laser In Situ; Methicillin Resistance; Moxifloxacin; Postoperative Complications; Quinolines; Rabbits; Specific Pathogen-Free Organisms; Staphylococcal Infections; Staphylococcus aureus; Surgical Flaps | 2008 |
Endophthalmitis.
Topics: Anti-Infective Agents; Antibiotic Prophylaxis; Aza Compounds; Bacteria; Endophthalmitis; Eye Infections, Bacterial; Fluoroquinolones; Gatifloxacin; Humans; Moxifloxacin; Ophthalmic Solutions; Phacoemulsification; Postoperative Complications; Quinolines; Vitreous Body | 2008 |